220 related articles for article (PubMed ID: 26159683)
1. Prognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival: evidence from four decades of US population data.
Hossain MJ; Xie L; Caywood EH
Cancer Epidemiol; 2015 Oct; 39(5):720-6. PubMed ID: 26159683
[TBL] [Abstract][Full Text] [Related]
2. Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data.
Hossain MJ; Xie L
Cancer Epidemiol; 2015 Dec; 39(6):892-900. PubMed ID: 26520618
[TBL] [Abstract][Full Text] [Related]
3. Survival differences in childhood and young adult acute myeloid leukemia: A cross-national study using US and England data.
Xie S; Hossain MJ
Cancer Epidemiol; 2018 Jun; 54():19-24. PubMed ID: 29554538
[TBL] [Abstract][Full Text] [Related]
4. Age and genetics: how do prognostic factors at diagnosis explain disparities in acute myeloid leukemia?
Patel MI; Ma Y; Mitchell BS; Rhoads KF
Am J Clin Oncol; 2015 Apr; 38(2):159-64. PubMed ID: 23608826
[TBL] [Abstract][Full Text] [Related]
5. Socioeconomic status (SES) and childhood acute myeloid leukemia (AML) mortality risk: Analysis of SEER data.
Knoble NB; Alderfer MA; Hossain MJ
Cancer Epidemiol; 2016 Oct; 44():101-108. PubMed ID: 27543948
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.
Kahn JM; Keegan TH; Tao L; Abrahão R; Bleyer A; Viny AD
Cancer; 2016 Sep; 122(17):2723-30. PubMed ID: 27286322
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and prognostic factors of pediatric brain tumor survival in the US: Evidence from four decades of population data.
Hossain MJ; Xiao W; Tayeb M; Khan S
Cancer Epidemiol; 2021 Jun; 72():101942. PubMed ID: 33946020
[TBL] [Abstract][Full Text] [Related]
8. Association of race and ethnicity with clinical phenotype, genetics, and survival in pediatric acute myeloid leukemia.
Conneely SE; McAtee CL; Gupta R; Lubega J; Scheurer ME; Rau RE
Blood Adv; 2021 Dec; 5(23):4992-5001. PubMed ID: 34619758
[TBL] [Abstract][Full Text] [Related]
9. Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt.
Sedeta E; Jemal A; Nisotel L; Sung H
Cancer; 2024 Jun; 130(11):1952-1963. PubMed ID: 38244208
[TBL] [Abstract][Full Text] [Related]
10. Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-2013.
Song X; Peng Y; Wang X; Chen Y; Jin L; Yang T; Qian M; Ni W; Tong X; Lan J
Acta Haematol; 2018; 139(2):115-127. PubMed ID: 29455198
[TBL] [Abstract][Full Text] [Related]
11. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country.
Lins MM; Mello MJG; Ribeiro RC; De Camargo B; de Fátima Pessoa Militão de Albuquerque M; Thuler LCS
Ann Hematol; 2019 Jun; 98(6):1403-1411. PubMed ID: 30915498
[TBL] [Abstract][Full Text] [Related]
12. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
Nasir SS; Giri S; Nunnery S; Martin MG
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
[TBL] [Abstract][Full Text] [Related]
13. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.
Kadan-Lottick NS; Ness KK; Bhatia S; Gurney JG
JAMA; 2003 Oct; 290(15):2008-14. PubMed ID: 14559954
[TBL] [Abstract][Full Text] [Related]
14. Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia.
Bhatnagar B; Kohlschmidt J; Mrózek K; Zhao Q; Fisher JL; Nicolet D; Walker CJ; Mims AS; Oakes C; Giacopelli B; Orwick S; Boateng I; Blachly JS; Maharry SE; Carroll AJ; Powell BL; Kolitz JE; Stone RM; Byrd JC; Paskett ED; de la Chapelle A; Garzon R; Eisfeld AK
Cancer Discov; 2021 Mar; 11(3):626-637. PubMed ID: 33277314
[TBL] [Abstract][Full Text] [Related]
15. Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia.
Xu LH; Wang Y; Chen ZY; Fang JP
J Cancer Res Clin Oncol; 2020 Apr; 146(4):1011-1020. PubMed ID: 31919567
[TBL] [Abstract][Full Text] [Related]
16. In-hospital Mortality and Racial Disparity in Children and Adolescents With Acute Myeloid Leukemia: A Population-based Study.
Castellanos MI; Dongarwar D; Wanser R; Caceres I; Park C; Rodriguez J; Salihu HM
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e114-e122. PubMed ID: 34001781
[TBL] [Abstract][Full Text] [Related]
17. Effects of poverty and race on outcomes in acute myeloid leukemia.
Byrne MM; Halman LJ; Koniaris LG; Cassileth PA; Rosenblatt JD; Cheung MC
Am J Clin Oncol; 2011 Jun; 34(3):297-304. PubMed ID: 20562587
[TBL] [Abstract][Full Text] [Related]
18. Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia.
Kamath GR; Tremblay D; Coltoff A; Caro J; Lancman G; Bhalla S; Najfeld V; Mascarenhas J; Taioli E
Carcinogenesis; 2019 Jul; 40(5):651-660. PubMed ID: 30715157
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.
Matsuo H; Nakamura N; Tomizawa D; Saito AM; Kiyokawa N; Horibe K; Nishinaka-Arai Y; Tokumasu M; Itoh H; Kamikubo Y; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Tanaka S; Adachi S
Pediatr Blood Cancer; 2016 Aug; 63(8):1394-9. PubMed ID: 27135782
[TBL] [Abstract][Full Text] [Related]
20. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.
Dores GM; Devesa SS; Curtis RE; Linet MS; Morton LM
Blood; 2012 Jan; 119(1):34-43. PubMed ID: 22086414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
